Coronary Stent Market Is Projected To Gain Massive Returns By 2017 : Radiant Insights,Inc

Rising prevalence of heart related-diseases has led to development of medical devices that can deter future ailments such as strokes or heart attacks. Coronary stents are instruments designed to prevent such heart conditions and aid surgeons in angioplasty and other related surgeries.

Complete Report Available @ https://www.radiantinsights.com/research/global-coronary-stent-industry-2017

Purpose of Coronary Stents

Coronary stents are devices used in extending the pathway of clogged arteries. According to a World Health Organization (WHO) study, in 2012, cardiovascular disorders (CVDs) accounted for more than 31% deaths globally. These devices can play an integral role in preventing such deaths in future. Since stents are made from metal and can rust over time, development of biodegradable stents is foreseen to have a major foothold in the medical device industry.

Novel Stents by Medical Device Companies to Boost Growth

Medtronic Japan Co. Ltd., a subsidiary of Medtronic PLC, launched the Resolute Onyx System in 2017. The drug-eluting stent (DES) is made of biopolymer and can deliver drugs more successfully through complex wounds. Its wire technology allows transparency in the transfer of drugs and can grip arterial walls. This development extends its application in treating percutaneous coronary intervention (PCI).

Bioresorbable vascular scaffolds (BVS) are devices used to support weak arterial walls. This promising innovation is dissolved in the body without harming the patient. The device has found support among the geriatric populace since it eliminates any complications while removing these stents in further surgeries. Abbott Laboratories recently received U.S. Food & Drug Administration (FDA) approval for its absorbable device, Abbott GT1 BVS in 2016.

Request A Sample Copy Of This Report at: https://www.radiantinsights.com/research/global-coronary-stent-industry-2017/request-sample

Market Insights

The global coronary stent market is projected to gain massive returns by 2022, according to a report on Radiant Insights, Inc. It is expected to showcase a strong CAGR over the forecast period (2012 – 2022) due to high prevalence of CVDs. Latest upgrades in stents are expected to reduce adverse effects experienced by drugs administered intravenously.

Drug-eluting stents (DES) gained maximum market share in 2015 due to their ability to reduce stent restenosis. Ambulatory surgery centers are projected to be the biggest end users in the market till 2022. North America may dominate the global market over the forecast period, followed by Europe. Noteworthy market players include Medtronic PLC, Abbott Laboratories, Terumo Corporation, and Boston Scientific Corporation.

About Radiant Insights,Inc

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Michelle Thoras
201 Spear Street 1100,
Suite 3036, San Francisco,
CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744
Mail: sales@radiantinsights.com

Web: http://www.radiantinsights.com/